China NMPA Drug Inspection - Gansu Fuxinghou Biomedical Technology Co., Ltd. - Eriocaulon
China NMPA drug inspection for Gansu Fuxinghou Biomedical Technology Co., Ltd. published July 16, 2021. Drug: Eriocaulon. On July 16, 2021, the Gansu Provincial Drug Administration released findings from a drug sampling inspection conducted b
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Gansu Fuxinghou Biomedical Technology Co., Ltd. published July 16, 2021. Drug: Eriocaulon. On July 16, 2021, the Gansu Provincial Drug Administration released findings from a drug sampling inspection conducted b
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox